iRhythm Technologies, Inc. (IRTC) Research
iRhythm Technologies, Inc. is a digital healthcare enterprise dedicated to offering portable electrocardiogram (ECG) monitoring solutions to individuals in the United States who face the risk of cardiac arrhythmias. Its primary offering, the Zio service, provides a comprehensive ambulatory cardiac monitoring system. This system ingeniously combines a wireless, patch-based, and wearable biosensor—specifically embodied in products like the Zio XT and AT monitors—with a sophisticated cloud-based data analysis platform. These single-use biosensors precisely record a patient's heartbeats and ECG data, thereby enabling medical professionals to effectively oversee patient heart health and accurately diagnose arrhythmias. Furthermore, iRhythm maintains a strategic development partnership with Verily Life Sciences LLC, focused on pioneering future atrial fibrillation screening, detection, and monitoring innovations. Founded in 2006, the company maintains its corporate headquarters in San Francisco, California.
Market snapshot
- Symbol
- IRTC
- Price
- $104.65
- Day change
- +2.81%
- Market cap
- $3.4B
- P/E ratio
- -122.44x
- 52-week range
- 100.8458-212
- Sector
- Healthcare
- Industry
- Medical - Devices
- Next earnings
- in 1 month
- Analyst price target
- $188.75
Recent news
- iRhythm discloses cyber incident, says no impact on device systems, patient safety
iRhythm Holdings on Monday reported unauthorized activity involving data maintained on some third-party applications last week, but said it has not identified any impact on products, patient safety or medical device systems from the cyber attack.
Peer companies
Recent insider activity
- Turakhia Minang — A-Award (137 shares) on 2026-05-29
- Patterson Chad — A-Award (177 shares) on 2026-05-29
- Freeman Sean Clinton — A-Award (273 shares) on 2026-05-29
- Blackford Quentin S. — A-Award (178 shares) on 2026-05-29
- Bairey Merz Cathleen Noel — A-Award (1573 shares) on 2026-05-27
Open iRhythm Technologies, Inc. (IRTC) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.